4-[4-[(3-chlorophenyl)methoxy]-2-[3-(dimethylamino)pyrrolidin-1-yl]pyrimidin-5-yl]sulfanylbenzonitrile
C24H24ClN5OS — CID 118515020
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-[(3-chlorophenyl)methoxy]-2-[3-(dimethylamino)pyrrolidin-1-yl]pyrimidin-5-yl]sulfanylbenzonitrile
4-[4-[(3-chlorophenyl)methoxy]-2-[3-(dimethylamino)pyrrolidin-1-yl]pyrimidin-5-yl]sulfanylbenzonitrile (PubChem CID 118515020) has the molecular formula C24H24ClN5OS and a molecular weight of 466.01 g/mol. Its IUPAC name is 4-[4-[(3-chlorophenyl)methoxy]-2-[3-(dimethylamino)pyrrolidin-1-yl]pyrimidin-5-yl]sulfanylbenzonitrile.
Molecular Properties
| Compound Name | 4-[4-[(3-chlorophenyl)methoxy]-2-[3-(dimethylamino)pyrrolidin-1-yl]pyrimidin-5-yl]sulfanylbenzonitrile |
|---|---|
| PubChem CID | 118515020 |
| Molecular Formula | C24H24ClN5OS |
| Molecular Weight | 466.01 g/mol |
| Exact Mass | 465.14 |
| IUPAC Name | 4-[4-[(3-chlorophenyl)methoxy]-2-[3-(dimethylamino)pyrrolidin-1-yl]pyrimidin-5-yl]sulfanylbenzonitrile |
| SMILES | CN(C)C1CCN(c2ncc(Sc3ccc(C#N)cc3)c(OCc3cccc(Cl)c3)n2)C1 |
| InChI | InChI=1S/C24H24ClN5OS/c1-29(2)20-10-11-30(15-20)24-27-14-22(32-21-8-6-17(13-26)7-9-21)23(28-24)31-16-18-4-3-5-19(25)12-18/h3-9,12,14,20H,10-11,15-16H2,1-2H3 |
| InChIKey | RTVRRCWHRDUYGJ-UHFFFAOYSA-N |
| XLogP | 4.87 |
| TPSA | 65.28 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 466.01 |
| LogP ≤ 5 | 4.87 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118515020 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.